BSE filing, BSE: 544504. Summary written from the filing by ALFA Finder's alert engine.
Goel Construction Company Ltd: key numbers
- Share price
- ₹405.40
- Market cap
- ₹585.8 Cr
- Revenue (annual)
- ₹657.3 Cr
- Net profit (annual)
- ₹46.26 Cr
- P/E (TTM)
- 12.7×Sector 31.3×
- Promoter holding
- 71.83%
- FII holding
- 0.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Goel Construction Company Ltd
All →Goel Construction Company Other Announcement
The company has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Goel Construction Company Business Update
Goel Construction reported a H1FY27 order book of ~₹1,300 crore. The company is diversifying into logistics, steel plants, and end-to-end infrastructure projects.
- Order book
- ₹1,300 Cr
Goel Construction Company Other Announcement
Goel Construction Company Ltd has updated its official contact telephone number. This disclosure serves as a routine intimation for regulatory records.
Goel Construction Company Board Meeting Outcome
Goel Construction Company's Board approved the company's Key Performance Indicators (KPIs) and the formation of a charitable Trust for CSR activities.
Goel Construction Company Management Change
Goel Construction Company Limited announced that Sushil Kumar Wali's designation changed from Additional Director to Non-Executive Independent Director, effective March 18, 2026.
Goel Construction Company Annual General Meeting
Goel Construction Company Ltd held its 29th AGM on August 31, 2026. Shareholders considered financial statements, director appointments, and increased borrowing powers.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.